Search Results for: teva pharmaceuticals

Israeli pharma giant Teva Pharmaceuticals has announced that its migraine treatment AJOVY has been found to also reduce symptoms of depression. AJOVY halts the activity of the protein CGRP, which causes inflammation and the widening of blood vessels in the brain. At the onset of a migraine, an individual has high levels of CGRP in […]

Pharma giant Teva has developed an effective treatment for patients who experience involuntary and repetitive body movements as a side effect from certain antipsychotic drugs.  Patients are at risk of developing tardive dyskinesia (TD) if they have been on high doses of certain medication for a long time. Symptoms include making involuntary noises or facial […]

A revolutionary schizophrenia treatment developed in Israel, which makes it easier for adult patients to manage their illness, has been granted approval by the US Food and Drug Administration, clearing the way for it to reach Americans in need as soon as this month.  Pharmaceutical companies Teva of Israel and Medincell of France have teamed […]

NoCamels spoke to AION Labs CTO Yair Benita about the benefits and challenges of bringing tech solutions into the pharmaceutical industry.

Cannbit-Tikun Olam Pharmaceuticals will produce medical cannabis products for Teva Israel, to be administered as oils rich in THC and CBD.

AION Labs, is a first-of-its-kind innovation lab spearheading the adoption of AI technologies and computational science

The BriLife vaccine will be tested in Phase II and III trials in Georgia, Ukraine, and Israel as part of a deal with NRx Pharmaceuticals.

Amai develops and produces protein-based products for food and drink, including a sweet designer protein as a substitute for sugar.

Israel’s Teva is partnering with the Technion for research into new immunotherapy methods to treat cancer and nervous system diseases.

Israel is home to close to 200 startups and companies with wide-ranging solutions to offer in the battle against the disease, not to mention the dozens of scientific initiatives.

The Israeli pharmaceutical giant says it will send some 6 million tablets of hydroxychloroquine sulfate, an FDA-approved malaria drug, to US hospitals.

The number of merger and acquisition deals in Israel were up 34 percent in 2019 with 166 deals made this year, compared to 124 deals in 2018, according to a new report released by PricewaterhouseCoopers (PwC) Israel this week. The overall value of a deal reached $20.4 billion, which was a six percent decrease from […]

The Israeli pharmaceutical giant signed separate agreements with the universities for innovative drug research and development with a focus on cancer treatments.

Teva's is the first generic naloxone hydrochloride nasal spray approved by the FDA.

Israel is the Startup Nation and consistently ranks as one of the world's top tech ecosystems, but it has some shortcomings that must be addressed. A special Passover piece.